Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 545292, 6 pages
http://dx.doi.org/10.1155/2015/545292
Research Article

Lack of Association between rs2067474 Polymorphism in Histamine Receptor H2 Gene and Breast Cancer in Chinese Han Population

1Department of Cardio-Thoracic Surgery, Kunming General Hospital of Chengdu Military Region, Kunming 650032, China
2Department of Pharmacy, Kunming General Hospital of Chengdu Military Region, Kunming 650032, China
3Hepatobiliary Surgery Center, 302 Hospital, Beijing 100039, China
4Department of Pharmacy, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an 710061, China
5Department of Anesthesiology, Affiliated Haikou Hospital, Xiangya School of Medicine, Central South University, Haikou 570208, China

Received 6 December 2014; Accepted 13 March 2015

Academic Editor: Jahn M. Nesland

Copyright © 2015 Wen-Ke Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Traiffort, M. Ruat, J.-M. Arrang, R. Leurs, D. Piomelli, and J.-C. Schwartz, “Expression of a cloned rat histamine H2 receptor mediating inhibition of arachidonate release and activation of cAMP accumulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 7, pp. 2649–2653, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Yamada, T. Tahara, H. Shiroeda et al., “Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy,” Journal of Gastrointestinal and Liver Diseases, vol. 21, no. 2, pp. 139–143, 2012. View at Google Scholar · View at Scopus
  3. G. He, J. Hu, T. Li et al., “Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia,” Molecular Medicine, vol. 18, no. 1, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H. L. Haas, O. A. Sergeeva, and O. Selbach, “Histamine in the nervous system,” Physiological Reviews, vol. 88, no. 3, pp. 1183–1241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Davio, A. Baldi, A. Mladovan et al., “Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas,” Inflammation Research, vol. 44, no. 1, supplement, pp. S70–S71, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. G. P. Cricco, C. A. Davio, G. Martin et al., “Histamine as an autocrine growth factor in experimental mammary carcinomas,” Agents and Actions, vol. 43, no. 1-2, pp. 17–20, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Davio, G. P. Cricco, G. Martin, C. P. Fitzsimons, R. M. Bergoc, and E. S. Rivera, “Effect of histamine on growth and differentiation of the rat mammary gland,” Agents and Actions, vol. 41, pp. C115–C117, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Parshad, P. Hazrah, S. Kumar, S. D. Gupta, R. Ray, and S. Bal, “Effect of preoperative short course famotidine on TILs and survival in breast cancer,” Indian Journal of Cancer, vol. 42, no. 4, pp. 185–190, 2005. View at Google Scholar · View at Scopus
  9. J. C. Porretti, N. A. Mohamad, G. A. Martín, and G. P. Cricco, “Fibroblasts induce epithelial to mesenchymal transition in breast tumor cells which is prevented by fibroblasts treatment with histamine in high concentration,” International Journal of Biochemistry and Cell Biology, vol. 51, no. 1, pp. 29–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. E. García-Martín, P. Ayuso, C. Martínez, M. Blanca, and J. A. G. Agúndez, “Histamine pharmacogenomics,” Pharmacogenomics, vol. 10, no. 5, pp. 867–883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Mancama, M. J. Arranz, J. Munro et al., “Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response,” Neuroscience Letters, vol. 333, no. 3, pp. 207–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Arisawa, T. Tahara, K. Ozaki et al., “Association between common genetic variant of HRH2 and gastric cancer risk,” International Journal of Oncology, vol. 41, no. 2, pp. 497–503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Nomura, T. Tahara, H. Shiroeda et al., “Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium,” BMC Gastroenterology, vol. 13, no. 1, article 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. García-Martín, P. Ayuso, A. Luengo, C. Martínez, and J. A. G. Agúndez, “Genetic variability of histamine receptors in patients with Parkinson's disease,” BMC Medical Genetics, vol. 9, article 15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. González-Neira, “Pharmacogenetics of chemotherapy efficacy in breast cancer,” Pharmacogenomics, vol. 13, no. 6, pp. 677–690, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Justenhoven, O. Obazee, and H. Brauch, “The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy,” Pharmacogenomics, vol. 13, no. 6, pp. 659–675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. G.-H. He, J. Lu, P.-P. Shi et al., “Polymorphisms of human histamine receptor H4 gene are associated with breast cancer in Chinese Han population,” Gene, vol. 519, no. 2, pp. 260–265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. G.-H. He, J.-J. Lin, W.-K. Cai et al., “Associations of polymorphisms in histidine decarboxylase, histamine N-methyltransferase and histamine receptor H3 genes with breast cancer,” PLoS ONE, vol. 9, no. 5, Article ID e97728, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Medina, G. Cricco, M. Nuñez et al., “Histamine-mediated signaling processes in human malignant mammary cells,” Cancer Biology and Therapy, vol. 5, no. 11, pp. 1462–1471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. V. A. Medina and E. S. Rivera, “Histamine receptors and cancer pharmacology,” British Journal of Pharmacology, vol. 161, no. 4, pp. 755–767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Blaya, F. Nicolau-Galmés, S. M. Jangi et al., “Histamine and histamine receptor antagonists in cancer biology,” Inflammation and Allergy - Drug Targets, vol. 9, no. 3, pp. 146–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Francis, S. DeMorrow, J. Venter et al., “Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma,” Gut, vol. 61, no. 5, pp. 753–764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. W.-K. Cai, J. Hu, T. Li et al., “Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer,” European Journal of Cancer, vol. 50, no. 6, pp. 1195–1206, 2014. View at Google Scholar · View at Scopus
  24. V. Medina, M. Croci, E. Crescenti et al., “The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment,” Cancer Biology and Therapy, vol. 7, no. 1, pp. 28–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. V. A. Medina, P. G. Brenzoni, D. J. M. Lamas et al., “Role of histamine H4 receptor in breast cancer cell proliferation,” Frontiers in Bioscience, vol. 3, no. 3, pp. 1042–1060, 2011. View at Google Scholar · View at Scopus
  26. J. Aurelius, A. Martner, M. Brune et al., “Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells,” Haematologica, vol. 97, no. 12, pp. 1904–1908, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. R. M. Pagotto, C. Monzón, M. B. Moreno, O. P. Pignataro, and C. Mondillo, “Proliferative effect of histamine on MA-10 leydig tumor cells mediated through HRH2 activation, transient elevation in cAMP production, and increased extracellular signal-regulated kinase phosphorylation levels,” Biology of Reproduction, vol. 87, no. 6, article 150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. P. F. Bowrey, J. King, C. Magarey et al., “Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?” British Journal of Cancer, vol. 82, no. 1, pp. 167–170, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Bolton, J. King, and D. L. Morris, “H2-antagonists in the treatment of colon and breast cancer,” Seminars in Cancer Biology, vol. 10, no. 1, pp. 3–10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. J. J. Michnovicz and R. A. Galbraith, “Cimetidine inhibits catechol estrogen metabolism in women,” Metabolism, vol. 40, no. 2, pp. 170–174, 1991. View at Publisher · View at Google Scholar · View at Scopus
  31. S. S. Tworoger, A. H. Eliassen, B. Rosner, P. Sluss, and S. E. Hankinson, “Plasma prolactin concentrations and risk of postmenopausal breast cancer,” Cancer Research, vol. 64, no. 18, pp. 6814–6819, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. P. F. Coogan, Y. Zhang, J. R. Palmer, B. L. Strom, and L. Rosenberg, “Cimetidine and other histamine2-receptor antagonist use in relation to risk of breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 4, pp. 1012–1015, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. R. W. Mathes, K. E. Malone, J. R. Daling, P. L. Porter, and C. I. Li, “Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 1, pp. 67–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. A. Moguilevsky, B. Szwarcfarb, M. R. Faigon, J. Paolini, and P. Scacchi, “Effects of H1 and H2 histamine receptor antagonists on positive feed-back effect of estrogen on LH in prepubertal female rats,” Hormone and Metabolic Research, vol. 21, no. 12, pp. 658–660, 1989. View at Publisher · View at Google Scholar · View at Scopus
  35. U. Knigge and J. Warberg, “The role of histamine in the neuroendocrine regulation of pituitary hormone secretion,” Acta Endocrinologica, vol. 124, no. 6, pp. 609–619, 1991. View at Google Scholar · View at Scopus